Ashish Mandelia

Insider Reports History

Location
840 Memorial Drive, Cambridge, MA
Signature
/s/ Alejandra Carvajal, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Ashish Mandelia:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Mersana Therapeutics, Inc. VP, Chief Accounting Officer Restricted Stock Unit 16.7K $45.2K $2.71 Jan 15, 2024 Direct
Mersana Therapeutics, Inc. VP, Chief Accounting Officer Common Stock 57.5K $33.4K $0.58 Jan 16, 2025 Direct
Mersana Therapeutics, Inc. VP, Chief Accounting Officer Restricted Stock Unit 16.7K $9.67K $0.58 Jan 15, 2025 Direct
Mersana Therapeutics, Inc. VP, Chief Accounting Officer Stock Option (Right to Buy) 75K Jan 15, 2025 Direct

Insider Reports Filed by Ashish Mandelia

Symbol Company Period Transactions Value $ Form Type Date Filed Role
MRSN Mersana Therapeutics, Inc. Jan 15, 2025 7 -$2.06K 4 Jan 17, 2025 VP, Chief Accounting Officer
MRSN Mersana Therapeutics, Inc. Jan 14, 2025 3 -$1.13K 4 Jan 16, 2025 VP, Chief Accounting Officer
MRSN Mersana Therapeutics, Inc. Jan 13, 2025 3 -$665 4 Jan 15, 2025 VP, Chief Accounting Officer
MRSN Mersana Therapeutics, Inc. Oct 1, 2024 4 -$16.3K 4 Oct 7, 2024 VP, Chief Accounting Officer
MRSN Mersana Therapeutics, Inc. Jan 13, 2024 0 $0 4/A Feb 16, 2024 VP, Chief Accounting Officer
MRSN Mersana Therapeutics, Inc. Jan 13, 2024 11 -$13.6K 4 Jan 17, 2024 VP, Chief Accounting Officer
MRSN Mersana Therapeutics, Inc. Sep 5, 2023 1 $0 4 Sep 7, 2023 VP, Chief Accounting Officer
MRSN Mersana Therapeutics, Inc. Jan 13, 2023 9 -$20.5K 4 Jan 18, 2023 VP, Controller
MRSN Mersana Therapeutics, Inc. Jan 14, 2022 6 -$11.7K 4 Jan 19, 2022 VP, Controller
MRSN Mersana Therapeutics, Inc. Jul 1, 2021 1 -$12.8K 4 Jul 2, 2021 VP, Controller